Biodesix, Inc. Net Debt/EBITDA

Net Debt/EBITDA of BDSX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Debt/EBITDA growth rates and interactive chart.


Highlights and Quick Summary

  • Net Debt/EBITDA for the quarter ending September 30, 2022 was -0.66 (a -287.15% decrease compared to previous quarter)
  • Year-over-year quarterly Net Debt/EBITDA decreased by -128.33%
  • Annual Net Debt/EBITDA for 2021 was 0.65 (a -73.2% decrease from previous year)
  • Annual Net Debt/EBITDA for 2020 was 2.42 (a -285.33% decrease from previous year)
  • Annual Net Debt/EBITDA for 2019 was -1.3 (a 25.24% increase from previous year)
Visit stockrow.com/BDSX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Debt/EBITDA of Biodesix, Inc.

Most recent Net Debt/EBITDAof BDSX including historical data for past 10 years.

Interactive Chart of Net Debt/EBITDA of Biodesix, Inc.

Biodesix, Inc. Net Debt/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.66 0.35 0.52
2021 2.33 1.6 2.48 4.67 0.65
2020 20.56 -15.05 0.0 0.0 2.42
2019 -16.0 0.0 -1.3
2018 -1.04

Business Profile of Biodesix, Inc.

Sector: Healthcare
Industry: Diagnostics & Research